Why are Medicare and Medicaid shown separately instead of combined?

They come from two different CMS data sources with no shared claim identifier, so they can't be reconciled into one number without double-counting or guessing. Every table and chart on this page keeps them fully separate.

Why is there no private/commercial revenue figure?

Private and commercial payer data comes from Transparency in Coverage files, which only publish negotiated rates — not claims or utilization volume. Without a volume figure, no revenue number can be computed for any provider from that data.

What does "Rank" mean in the Competitive Analysis & Benchmarks tables?

For a given CPT/HCPCS code, it's this provider's position by claims volume among all providers billing that same code at that geography level (State, National, or Ohio for Medicaid) — rank 1 means the highest claims volume for that code.

Why is the Medicaid comparison limited to Ohio only?

Medicaid is administered per-state with no single national fee schedule, so a state or national comparison the way Medicare has one isn't available. Ohio (this provider's own state) is the only grouping that's conceptually meaningful.

Why are the numbers rounded to the nearest 10?

To avoid implying more precision than the underlying data supports at a single-provider level. Ratios are kept precise since they're a relative comparison, not a volume or dollar figure.

How current is this data?

The Medicare and Medicaid tables are both single current snapshots, not refreshed on a recurring schedule yet.

Matthew Byun (NPI 1558781922)

Field	Value
Entity Type	Individual
Organization	Matthew Byun
Address	262 Neil Ave Ste 220
City	Columbus
State	OH
ZIP	43215
Taxonomy	Retina Specialist (Ophthalmology) Physician
NPI Enumerated	April 23, 2014

Payer Source	Total Paid
Medicare	$2.4M
Medicaid	$0

Key Findings

MATTHEW BYUN is a retina specialist (Ophthalmology) physician in COLUMBUS, OH with Total Medicare revenue of $2.4M and no Medicaid billing on file; the NPI was enumerated on 2014-04-23 (~12 years ago), indicating roughly a decade of enrolled Medicare participation. The absence of Medicaid activity in the file makes this an effectively single-payer (Medicare) billing profile in the available data.

Revenue is highly concentrated in a few intravitreal drug and injection-related codes: the precomputed top 3 Medicare codes by revenue (J0178, J2777, 67028) account for 90.3% of this provider's total Medicare revenue. Specifically, J0178 represents 65.4% of Medicare revenue, J2777 19.4%, and 67028 5.5%, signaling that pharmacologic intravitreal therapy is the dominant revenue driver.

The code mix identifies the clinical operation as a procedure- and drug-focused retina practice: heavy use of J0178 (aflibercept) and J2777 (faricimab) plus 67028 (intravitreal injection) indicates primary activity is outpatient intravitreal injections for retinal disease management. Secondary services appear to include intravitreal implants and unclassified biologics (J7312, J3590) and limited surgical procedures (e.g., 67036), consistent with a retina-focused ambulatory practice model rather than a broad multispecialty clinic.

Despite J0178 producing $1.6M (65.4% of Medicare revenue) and J2777 producing $461.1K (19.4% of Medicare revenue), the reported peer labels characterize the provider’s volumes for these codes as typical or unremarkable nationally (J0178: ranks #410 of 3204, 87th percentile; described as "typical, unremarkable volume"; J2777: ranks #671 of 2039, 67th percentile; described as "typical, unremarkable volume"). In other words, the provider is a substantive biller for those drugs in absolute dollars but is not flagged as an extreme national outlier in claims volume for those specific codes.

There are notable areas of above-typical activity outside the drug-dominated revenue: 92134 (retinal imaging) and 99213 (established office E/M) are labeled "notably above typical" (92134: ranks #1101 of 26868, 96th percentile; 99213: ranks #20605 of 457151, 95th percentile). These patterns suggest relatively high diagnostic imaging throughput and frequent follow-up office visits, supporting a workflow that pairs intravitreal therapy with intensive monitoring and routine E/M visits.

Surgical and advanced procedural codes account for only small shares of revenue, which points to limited surgical caseload relative to injection-based care: 67036, 67228 and J7312 appear in the top codes but contribute modest revenue compared with the intravitreal drugs and injection procedure. The presence of these codes shows capability for a broader retinal service line, but they are secondary to outpatient injection services.

From a competitive standing perspective, the provider occupies a solid but not dominant national position on the highest-revenue drug codes: ranks and percentiles for leading codes place the practice in the mid-to-upper peer distribution without being classified as an extreme outlier. Simultaneously, the very high percentiles for 92134 and 99213 indicate the practice is comparatively high-volume for retinal imaging and routine E/M, which may be a differentiator in diagnostic capacity and follow-up management relative to many peers.

Medicare: Complete Services Breakdown

The CPT/HCPCS codes generating the most Medicare revenue for this provider.

17 rows

CPT/HCPCS Code	Description	Claims	Avg Paid	Revenue
J0178	Injection, aflibercept, 1 mg	2,260	$690	$1.6M
J2777	Injection, faricimab‑svoa, 0.1 mg	15,900	$30	$461.1K
67028	The provider injects a medication into the vitreous chamber of the eye as an isolated procedure or a separate procedure unrelated to any other procedure being performed on the eye.	1,450	$90	$131.6K
J7312	Injection, dexamethasone, intravitreal implant, 0.1 mg	410	$160	$64K
92134	The provider performs computerized diagnostic imaging of the retina in the posterior segment (back part) of the eye, interprets the data, and provides a report. The service may be on one or both eyes.	1,930	$30	$54K
99213	The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a low level of medical decision making, and/or the…	580	$60	$35.4K
J3590	Unclassified biologics	340	$80	$27.7K
99214	The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the…	110	$90	$9.3K
99204	The provider sees a new patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the provider…	80	$110	$9.3K
67228	In retinopathy, tiny new vessels grow profusely and fibrous tissue proliferates in between the layers of the retina, which may extend into the optic nerve and vitreous, clear gel that fills the space…	30	$260	$8.3K

Showing 1–10 of 17

Medicare: Competitive Analysis & Benchmarks

How this provider's Medicare billing volume and revenue compare to other providers nationally and within its state, across 17 CPT/HCPCS codes.

View: State1 / 2

Claims Volume vs. Ohio Distribution

Matthew Byun — 2 of 17 codes billed far more than typical (above p95)

p5–p95 (all providers)p25–p75MedianThis providerOutlier

Rank Distribution — Ohio

Full comparison — all codes billed, vs. state median

17 rows

CPT/HCPCS Code	Rank	Provider Count	Median Claims	Avg Paid	Average Revenue
J0178	15	100	840	$680	$729K
J2777	19	70	9,480	$30	$353.3K
67028	29	150	470	$90	$64K
J7312	5	20	240	$160	$41.7K
J3590	41	100	200	$100	$30K
67036	38	50	20	$870	$21K
99214	9,106	20,010	100	$70	$11.7K
99213	489	20,000	70	$50	$6.6K
92134	36	1,010	50	$30	$6.3K
67228	4	20	20	$250	$6.1K

Showing 1–10 of 17

Related Providers

Other providers that share a Tax Identification Number (TIN) with Matthew Byun, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
Christiane Hunt	OH	Retina Specialist (Ophthalmology) Physician	$2.3M	$0
Chirag Patel	OH	Retina Specialist (Ophthalmology) Physician	$2.1M	$0
Lisa Borkowski	OH	Ophthalmology Physician	$1.3M	$0
Mashal Akhter	OH	Retina Specialist (Ophthalmology) Physician	$695.2K	$0

Nearby Providers

Other providers in the same ZIP code as Matthew Byun, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
Ohiohealth Corporation	OH	General Acute Care Hospital	$0	$215.2M
Columbus Radiology Corp	OH	Diagnostic Radiology Physician	$0	$49.9M
Southeast, Inc	OH	Mental Health Clinic/Center (Including Community Mental Health Center)	$0	$40.8M
Mid-ohio Emergency Services, LLC	OH	Emergency Medicine Physician	$0	$38.5M
Nationwide Children's Hospital	OH	Home Infusion Agency	$0	$22.4M
Ohio Emergency Professionals Inc	OH	Emergency Medicine Physician	$0	$21.5M
Premier Care Of Ohio, LLC	OH	Methadone Clinic	$0	$18.2M
Nationwide Children's Hospital Homecare	OH	Home Health Agency	$0	$17.5M
Forward Health LLC	OH	Substance Use Disorder Rehabilitation Clinic/Center	$0	$12.1M
Nationwide Children's Hospital	OH	Dental Clinic/Center	$0	$11.1M

Matthew Byun — Billing Profile & Reimbursement Data

Sign up for Matthew Byun — Billing Profile & Reimbursement Data policy alerts

Matthew Byun — Billing Profile & Reimbursement Data

Sign up for Matthew Byun — Billing Profile & Reimbursement Data policy alerts

Key Findings

Medicare: Total Revenue Breakdown by CPT/HCPCS Code

Medicare: Complete Services Breakdown

Medicare: Competitive Analysis & Benchmarks

Related Providers

Nearby Providers

Frequently Asked Questions

References